Avadel Pharmaceuticals (NASDAQ:AVDL) Price Target Raised to $16.00 at LADENBURG THALM/SH SH

Avadel Pharmaceuticals (NASDAQ:AVDL – Get Rating) had its target price lifted by analysts at LADENBURG THALM/SH SH from $14.50 to $16.00 in a research report issued to clients and investors on Tuesday, The Fly reports. LADENBURG THALM/SH SH’s price target indicates a potential upside of 36.40% from the company’s current price. Other research analysts have […]

Related Keywords

,Analyst Recommendations For Avadel Pharmaceuticals ,Avadel Pharmaceuticals Plc ,Avadel Pharmaceuticals Stock Performance ,Blackrock Inc ,Polar Capital Holdings Plc ,News Ratings For Avadel Pharmaceuticals Daily ,Institutional Trading Of Avadel Pharmaceuticals ,Nasdaq ,Avadel Pharmaceuticals ,Needham Company ,Get Rating ,Lifesci Capital ,Gate Manager ,Street Corp ,Capital Holdings Plc ,Pharmaceuticals Plc ,Avadel Pharmaceuticals Daily ,Nasdaq Avdl ,Avdl ,Medical ,Boost Price Target ,Ladenburg Thalm Sh ,